OLEMA PHARMACEUTICALS INC (OLMA) Stock Cash Flow
USA - NASDAQ:OLMA - US68062P1066 - Common Stock
8.72 USD
-0.07 (-0.8%)
8.73 USD
+0.01 (+0.11%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -142.29M | -129.47M | -96.66M | -104.79M | -71.10M | |||
| Depreciation Amortization | 471.00K | 393.00K | 377.00K | 360.00K | 160.00K | |||
| Change In Working Capital | -73.00K | 9.16M | -589.00K | 3.02M | 2.83M | |||
| Other non cash items | 14.73M | 15.57M | 13.14M | 19.34M | 17.41M | |||
| OPERATING CASH FLOW | -127.16M | -104.35M | -83.73M | -82.07M | -50.69M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -159.00K | 0.00 | -360.00K | -1.58M | |||
| Other Investing Activity | -79.35M | -93.37M | -4.85M | 91.84M | -273.86M | |||
| INVESTING CASH FLOW | -79.35M | -93.53M | -4.85M | 91.48M | -275.44M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 2.11M | 25.32M | 3.68M | 480.00K | 1.39M | |||
| Other Financing Activity | N/A | 243.50M | 129.74M | N/A | N/A | |||
| FINANCING CASH FLOW | 242.10M | 268.82M | 133.41M | 480.00K | 1.39M | |||
| CHANGE IN CASH | 35.58M | 70.94M | 44.84M | 9.89M | -324.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -127.16M | -104.35M | -83.73M | -82.07M | -50.69M | |||
| Capital Expenditure | N/A | -159.00K | 0.00 | -360.00K | -1.58M | |||
| FREE CASH FLOW | -127.16M | -104.51M | -83.73M | -82.43M | -52.27M | |||
All data in USD